Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study.
Benderra MA, Aparicio A, Leblanc J, Wassermann D, Kempf E, Galula G, Bernaux M, Canellas A, Moreau T, Bellamine A, Spano JP, Daniel C, Champ J, Canouï-Poitrine F, Gligorov J, On Behalf Of The Ap-Hp/Universities/Inserm Covid-Research Collaboration, Cancer Ap-Hp Group Covid-Task Force, Ap-Hp Covid Cdw Initiative Acci. Benderra MA, et al. Among authors: gligorov j. Cancers (Basel). 2021 Sep 23;13(19):4749. doi: 10.3390/cancers13194749. Cancers (Basel). 2021. PMID: 34638235 Free PMC article.
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study.
Launay-Vacher V, Spano JP, Janus N, Gligorov J, Ray-Coquard I, Oudard S, Pourrat X, Morere JF, Beuzeboc P, Deray G; Renal Insufficiency and Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: gligorov j. Crit Rev Oncol Hematol. 2009 May;70(2):124-33. doi: 10.1016/j.critrevonc.2008.09.012. Epub 2008 Nov 5. Crit Rev Oncol Hematol. 2009. PMID: 18990585
[Renal insufficiency and breast cancer].
Beuzeboc P, Le Tourneau C, Gligorov J, Janus N, Spano JP, Ray-Coquard I, Deray G, Launay-Vacher V. Beuzeboc P, et al. Among authors: gligorov j. Bull Cancer. 2012 Mar 1;99(3):309-15. doi: 10.1684/bdc.2011.1478. Bull Cancer. 2012. PMID: 22106161 Free article. French.
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study.
Pivot X, Spano JP, Espie M, Cottu P, Jouannaud C, Pottier V, Moreau L, Extra JM, Lortholary A, Rivera P, Spaeth D, Attar-Rabia H, Benkanoun C, Dima-Martinez L, Esposito N, Gligorov J. Pivot X, et al. Among authors: gligorov j. Eur J Cancer. 2017 Sep;82:230-236. doi: 10.1016/j.ejca.2017.05.009. Epub 2017 Jun 23. Eur J Cancer. 2017. PMID: 28648618 Clinical Trial.
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).
Chumsri S, Sperinde J, Liu H, Gligorov J, Spano JP, Antoine M, Moreno Aspitia A, Tan W, Winslow J, Petropoulos CJ, Chenna A, Bates M, Weidler JM, Huang W, Dueck A, Perez EA. Chumsri S, et al. Among authors: gligorov j. Clin Cancer Res. 2018 Jul 1;24(13):3053-3058. doi: 10.1158/1078-0432.CCR-17-1864. Epub 2018 Mar 12. Clin Cancer Res. 2018. PMID: 29530935 Free PMC article.
[Manual for "Junior Doctors" in medical oncology].
Rousseau A, Ashton E, Naoun N, Cren PY, Gligorov J, Negrier S, Penel N, Spano JP. Rousseau A, et al. Among authors: gligorov j. Bull Cancer. 2021 Apr;108(4):377-384. doi: 10.1016/j.bulcan.2021.02.002. Epub 2021 Mar 19. Bull Cancer. 2021. PMID: 33745736 French.
[Goals, motivations, and difficulties of young oncology residents].
Hilmi M, Ashton E, Delaye M, Giraud P, Neuzillet C, Spano JP, Gligorov J, Ollivier L, Rousseau A, Naoun N, Boilève A. Hilmi M, et al. Among authors: gligorov j. Bull Cancer. 2022 Feb;109(2):119-129. doi: 10.1016/j.bulcan.2021.09.020. Epub 2021 Nov 19. Bull Cancer. 2022. PMID: 34809979 French.
240 results